Pharmaceutical Pricing and Innovation Key Issues for 2003

The establishment of a Medicare pharmacy benefit tops the to-do list of industry-related policy issues for 2003.

Related Content:

Regulatory WatchPharmaceutical Technology-01-01-2003

Major Challenges Ahead for FDA and Pharma

FDA Grapples with the Promise and Perils of Gene Therapy

Pandemic Alters Policies and Practices for Drug Development and Regulation